Advertisement
Australia markets open in 6 hours 57 minutes
  • ALL ORDS

    7,849.40
    +17.50 (+0.22%)
     
  • AUD/USD

    0.6557
    +0.0029 (+0.45%)
     
  • ASX 200

    7,587.00
    +17.10 (+0.23%)
     
  • OIL

    79.02
    +0.02 (+0.03%)
     
  • GOLD

    2,312.30
    +1.30 (+0.06%)
     
  • Bitcoin AUD

    90,021.33
    +3,194.17 (+3.68%)
     
  • CMC Crypto 200

    1,272.89
    +2.15 (+0.17%)
     

While institutions own 40% of Integral Diagnostics Limited (ASX:IDX), retail investors are its largest shareholders with 44% ownership

Key Insights

  • Significant control over Integral Diagnostics by retail investors implies that the general public has more power to influence management and governance-related decisions

  • 50% of the business is held by the top 22 shareholders

  • 40% of Integral Diagnostics is held by Institutions

To get a sense of who is truly in control of Integral Diagnostics Limited (ASX:IDX), it is important to understand the ownership structure of the business. We can see that retail investors own the lion's share in the company with 44% ownership. In other words, the group stands to gain the most (or lose the most) from their investment into the company.

Meanwhile, institutions make up 40% of the company’s shareholders. Generally speaking, as a company grows, institutions will increase their ownership. Conversely, insiders often decrease their ownership over time.

ADVERTISEMENT

In the chart below, we zoom in on the different ownership groups of Integral Diagnostics.

Check out our latest analysis for Integral Diagnostics

ownership-breakdown
ownership-breakdown

What Does The Institutional Ownership Tell Us About Integral Diagnostics?

Institutional investors commonly compare their own returns to the returns of a commonly followed index. So they generally do consider buying larger companies that are included in the relevant benchmark index.

Integral Diagnostics already has institutions on the share registry. Indeed, they own a respectable stake in the company. This suggests some credibility amongst professional investors. But we can't rely on that fact alone since institutions make bad investments sometimes, just like everyone does. When multiple institutions own a stock, there's always a risk that they are in a 'crowded trade'. When such a trade goes wrong, multiple parties may compete to sell stock fast. This risk is higher in a company without a history of growth. You can see Integral Diagnostics' historic earnings and revenue below, but keep in mind there's always more to the story.

earnings-and-revenue-growth
earnings-and-revenue-growth

We note that hedge funds don't have a meaningful investment in Integral Diagnostics. The company's largest shareholder is Yarra Funds Management Limited, with ownership of 7.6%. The second and third largest shareholders are Viburnum Funds Pty Ltd. and State Street Global Advisors, Inc., with an equal amount of shares to their name at 5.0%.

A closer look at our ownership figures suggests that the top 22 shareholders have a combined ownership of 50% implying that no single shareholder has a majority.

While it makes sense to study institutional ownership data for a company, it also makes sense to study analyst sentiments to know which way the wind is blowing. There are plenty of analysts covering the stock, so it might be worth seeing what they are forecasting, too.

Insider Ownership Of Integral Diagnostics

While the precise definition of an insider can be subjective, almost everyone considers board members to be insiders. Company management run the business, but the CEO will answer to the board, even if he or she is a member of it.

Most consider insider ownership a positive because it can indicate the board is well aligned with other shareholders. However, on some occasions too much power is concentrated within this group.

We can report that insiders do own shares in Integral Diagnostics Limited. As individuals, the insiders collectively own AU$9.6m worth of the AU$567m company. This shows at least some alignment. You can click here to see if those insiders have been buying or selling.

General Public Ownership

The general public, who are usually individual investors, hold a 44% stake in Integral Diagnostics. This size of ownership, while considerable, may not be enough to change company policy if the decision is not in sync with other large shareholders.

Private Equity Ownership

With an ownership of 5.0%, private equity firms are in a position to play a role in shaping corporate strategy with a focus on value creation. Sometimes we see private equity stick around for the long term, but generally speaking they have a shorter investment horizon and -- as the name suggests -- don't invest in public companies much. After some time they may look to sell and redeploy capital elsewhere.

Private Company Ownership

We can see that Private Companies own 7.5%, of the shares on issue. It's hard to draw any conclusions from this fact alone, so its worth looking into who owns those private companies. Sometimes insiders or other related parties have an interest in shares in a public company through a separate private company.

Next Steps:

It's always worth thinking about the different groups who own shares in a company. But to understand Integral Diagnostics better, we need to consider many other factors. For example, we've discovered 1 warning sign for Integral Diagnostics that you should be aware of before investing here.

But ultimately it is the future, not the past, that will determine how well the owners of this business will do. Therefore we think it advisable to take a look at this free report showing whether analysts are predicting a brighter future.

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.